HBM Healthcare Investments AG
Manages a global portfolio of private and public companies in the healthcare sector.
HBMN | SW
Overview
Corporate Details
- ISIN(s):
- CH0012627250 (+2 more)
- LEI:
- 549300IFDFSDRT4D3076
- Country:
- Switzerland
- Address:
- Bundesplatz 1, 6300 Zug
- Website:
- https://www.hbmhealthcare.com/en
Description
HBM Healthcare Investments AG is an investment company managing a globally diversified portfolio of private and public companies within the healthcare sector. The firm focuses on investing in promising enterprises across various stages of development, from start-ups to mature companies, in fields such as human medicine, biotechnology, medical technology, and diagnostics. It provides strategic support to its portfolio companies, targeting emerging technologies and innovations to drive value creation. The investment strategy aims to capitalize on long-term growth drivers in the healthcare market, including medical progress and the increasing global demand for new therapies and medical services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-06-17 18:26 |
Key Figures
15.06.2022
|
English | HTML • 14.2 KB | ||
| 2022-06-17 02:00 |
Key Figures
15.06.2022
|
English | HTML • 12.0 KB | ||
| 2022-06-10 17:46 |
Shareholders Meeting of HBM Healthcare Investments approved all proposals by th…
|
English | HTML • 6.2 KB | ||
| 2022-06-10 02:00 |
Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by t…
|
English | HTML • 4.4 KB | ||
| 2022-06-10 02:00 |
Generalversammlung der HBM Healthcare Investments stimmt allen Anträgen des Ver…
|
German | HTML • 4.3 KB | ||
| 2022-06-03 17:46 |
Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutic…
|
English | HTML • 6.0 KB | ||
| 2022-06-03 02:00 |
Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutic…
|
English | HTML • 4.2 KB | ||
| 2022-06-03 02:00 |
Bristol Myers Squibb erwirbt HBM-Portfoliounternehmen Turning Point Therapeutic…
|
German | HTML • 4.3 KB | ||
| 2022-06-01 17:46 |
Key Figures
31.05.2022
|
English | HTML • 14.2 KB | ||
| 2022-06-01 02:00 |
Key Figures
31.05.2022
|
English | HTML • 12.0 KB | ||
| 2022-05-18 06:46 |
Publication of Annual Report 2021/2022 and Invitation to the Ordinary Sharehold…
|
English | HTML • 7.7 KB | ||
| 2022-05-16 17:47 |
Key Figures
15.05.2022
|
English | HTML • 14.2 KB | ||
| 2022-05-10 18:25 |
Pfizer to acquire HBM portfolio company Biohaven Pharmaceuticals in USD 11.6 bi…
|
English | HTML • 5.6 KB | ||
| 2022-05-06 06:40 |
HBM Healthcare Investments year-end results 2021/2022
|
English | HTML • 19.2 KB | ||
| 2022-05-02 17:46 |
Key Figures
30.04.2022
|
English | HTML • 14.2 KB |
Automate Your Workflow. Get a real-time feed of all HBM Healthcare Investments AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HBM Healthcare Investments AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HBM Healthcare Investments AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-22 | N/A | Non-Executive member | Sell | None | 34,860.00 CHF |
| 2025-04-03 | N/A | Non-Executive member | Sell | None | 110,217.50 CHF |
| 2025-04-01 | N/A | Non-Executive member | Buy | None | 140,010.00 CHF |
| 2025-04-01 | N/A | Non-Executive member | Buy | None | 100,007.50 CHF |
| 2024-12-19 | N/A | Non-Executive member | Buy | None | 53,760.00 CHF |
| 2024-12-17 | N/A | Non-Executive member | Buy | None | 48,256.00 CHF |
| 2024-11-06 | N/A | Executive member | Buy | None | 91,123.80 CHF |
| 2024-07-02 | N/A | Non-Executive member | Buy | None | 49,200.00 CHF |
| 2024-06-04 | N/A | Executive member | Sell | None | 52,750.00 CHF |
| 2024-04-03 | N/A | Non-Executive member | Buy | None | 139,944.05 CHF |
Peer Companies
